Gluconeogenesis- Steps, Reactions and Significance

Gluconeogenesis is the process of synthesizing glucose from non-carbohydrate sources, such as lactate, pyruvate, glycerol, and certain amino acids. Glucose is the main source of energy for most cells in the body, especially the brain and red blood cells. Gluconeogenesis ensures that the blood glucose level is maintained within a normal range when dietary intake or glycogen stores are insufficient.

Gluconeogenesis is not simply the reversal of glycolysis, which is the breakdown of glucose to pyruvate. Although some of the reactions are the same, there are three irreversible steps in glycolysis that must be bypassed by different enzymes in gluconeogenesis. These steps are:

• The conversion of glucose to glucose-6-phosphate by hexokinase or glucokinase
• The conversion of fructose-6-phosphate to fructose-1,6-bisphosphate by phosphofructokinase-1
• The conversion of phosphoenolpyruvate to pyruvate by pyruvate kinase

The enzymes that catalyze these steps in gluconeogenesis are:

• Glucose-6-phosphatase, which converts glucose-6-phosphate to glucose
• Fructose-1,6-bisphosphatase, which converts fructose-1,6-bisphosphate to fructose-6-phosphate
• Pyruvate carboxylase and phosphoenolpyruvate carboxykinase, which convert pyruvate to phosphoenolpyruvate

Gluconeogenesis is regulated by hormonal and allosteric factors that control the activity of these key enzymes. The main hormones that stimulate gluconeogenesis are glucagon and cortisol, which are secreted during fasting, stress, or low blood glucose levels. The main hormones that inhibit gluconeogenesis are insulin and epinephrine, which are secreted during feeding, exercise, or high blood glucose levels. The allosteric factors include the substrates and products of the reactions, as well as other metabolites that reflect the energy status of the cell.

Gluconeogenesis is an important metabolic pathway that allows the body to maintain a steady supply of glucose for vital functions. It also helps to clear excess lactate and amino acids from the blood and prevent their accumulation. Gluconeogenesis requires energy and reducing equivalents from other sources, such as fatty acids and amino acids. Therefore, it is coordinated with other pathways of carbohydrate, lipid, and protein metabolism.

Gluconeogenesis is the process of synthesizing glucose from non-carbohydrate sources such as lactate, pyruvate, glycerol, and certain amino acids. Gluconeogenesis occurs mainly in the liver, which accounts for about 90% of the total glucose production in the body. The kidney also contributes to gluconeogenesis, especially during prolonged fasting or starvation. The intestine can also produce glucose from dietary sources such as fructose and galactose.

The location of gluconeogenesis depends on the availability of substrates and enzymes. The first reaction of gluconeogenesis (the conversion of pyruvate to oxaloacetate) takes place in the mitochondria, whereas the rest of the reactions occur in the cytosol. The mitochondria are the site of oxidative metabolism and provide energy and reducing equivalents for gluconeogenesis. The cytosol is where most of the glycolytic enzymes are located and where glucose is formed and released into the blood.

The transport of substrates and intermediates between the mitochondria and the cytosol is facilitated by specific transporters and carriers. For example, oxaloacetate cannot directly cross the inner mitochondrial membrane, so it is converted to malate or aspartate, which can be transported to the cytosol and reconverted to oxaloacetate. Similarly, phosphoenolpyruvate (PEP), which is formed from oxaloacetate in the cytosol, can be transported back to the mitochondria as pyruvate or alanine.

The regulation of gluconeogenesis is coordinated by hormonal and allosteric factors that control the activity and expression of key enzymes. Gluconeogenesis is stimulated by glucagon, cortisol, and epinephrine, which increase the levels of cyclic AMP and activate protein kinase A. Gluconeogenesis is inhibited by insulin, which promotes glycolysis and glycogen synthesis. Gluconeogenesis is also modulated by the availability of substrates and energy. High levels of lactate, pyruvate, alanine, or glycerol increase gluconeogenesis, whereas high levels of glucose or ATP inhibit it.

Gluconeogenesis is essential for maintaining blood glucose levels and providing energy for tissues that depend on glucose as a fuel source, such as the brain and red blood cells. Gluconeogenesis also helps to clear excess lactate and amino acids from the blood and prevent metabolic acidosis. Gluconeogenesis is a complex and highly regulated process that involves multiple organs and compartments in the body.

Gluconeogenesis is the process of synthesizing glucose from non-carbohydrate precursors, such as pyruvate, lactate, glycerol, and certain amino acids. The major steps involved in gluconeogenesis are:

• Conversion of pyruvate to oxaloacetate: Pyruvate, which is produced from lactate, alanine, and other amino acids, is first converted to oxaloacetate by the enzyme pyruvate carboxylase. This reaction takes place in the mitochondria and requires biotin and ATP as cofactors. Oxaloacetate is an intermediate of the citric acid cycle and can also be derived from aspartate.

• Conversion of oxaloacetate to phosphoenolpyruvate: Oxaloacetate cannot cross the inner mitochondrial membrane, so it has to be transported to the cytosol where the rest of the gluconeogenic reactions occur. To do this, oxaloacetate is either reduced to malate by malate dehydrogenase or transaminated to aspartate by aspartate aminotransferase. Malate or aspartate can then cross the mitochondrial membrane and be reconverted to oxaloacetate in the cytosol. Oxaloacetate is then decarboxylated and phosphorylated by the enzyme phosphoenolpyruvate carboxykinase (PEPCK) to form phosphoenolpyruvate (PEP). This reaction requires GTP as a cofactor.

• Formation of fructose 1,6-bisphosphate: PEP is then converted to fructose 1,6-bisphosphate by reversing the steps of glycolysis. This involves the following reactions:

  • PEP is converted to 2-phosphoglycerate by enolase.
  • 2-phosphoglycerate is converted to 3-phosphoglycerate by phosphoglycerate mutase.
  • 3-phosphoglycerate is converted to 1,3-bisphosphoglycerate by phosphoglycerate kinase, using ATP.
  • 1,3-bisphosphoglycerate is converted to glyceraldehyde 3-phosphate by glyceraldehyde 3-phosphate dehydrogenase, using NADH.
  • Glyceraldehyde 3-phosphate is combined with dihydroxyacetone phosphate (DHAP) by triose phosphate isomerase to form fructose 1,6-bisphosphate.

• Conversion of fructose 1,6-bisphosphate to fructose-6-phosphate: Fructose 1,6-bisphosphate is then hydrolyzed by the enzyme fructose 1,6-bisphosphatase to form fructose-6-phosphate. This is one of the key regulatory steps in gluconeogenesis.

• Conversion of fructose-6-phosphate to glucose-6-phosphate: Fructose-6-phosphate is then isomerized to glucose-6-phosphate by the enzyme glucose-6-phosphate isomerase.

• Conversion of glucose-6-phosphate to free glucose: Glucose-6-phosphate is then dephosphorylated by the enzyme glucose-6-phosphatase to form free glucose. This enzyme is located in the endoplasmic reticulum of liver and kidney cells and releases glucose into the blood. This is another key regulatory step in gluconeogenesis.

The net result of these steps is that two molecules of pyruvate are converted to one molecule of glucose, using four molecules of ATP, two molecules of GTP, and two molecules of NADH. Gluconeogenesis consumes more energy than glycolysis produces, which reflects the importance of maintaining blood glucose levels.

Gluconeogenesis involves three reactions that are different from glycolysis and seven reactions that are the reverse of glycolysis. The three different reactions are:

• Conversion of pyruvate to phosphoenolpyruvate
• Conversion of fructose 1,6-bisphosphate to fructose-6-phosphate
• Conversion of glucose-6-phosphate to glucose

Let`s look at each of these reactions in detail.

Conversion of pyruvate to phosphoenolpyruvate

This reaction is the first step of gluconeogenesis and it occurs in two stages. The first stage takes place in the mitochondria and the second stage takes place in the cytosol.

In the first stage, pyruvate is carboxylated by pyruvate carboxylase, an enzyme that requires biotin and ATP as cofactors. The product of this reaction is oxaloacetate, a four-carbon compound.

Oxaloacetate cannot cross the inner mitochondrial membrane, so it has to be transported to the cytosol by one of two ways:

• It can be reduced to malate by malate dehydrogenase, an enzyme that uses NADH as a cofactor. Malate can cross the mitochondrial membrane and then be oxidized back to oxaloacetate by malate dehydrogenase in the cytosol, using NAD+ as a cofactor. This process also transfers reducing equivalents (NADH) from the mitochondria to the cytosol.
• It can be transaminated to aspartate by aspartate aminotransferase, an enzyme that uses glutamate as a cofactor. Aspartate can cross the mitochondrial membrane and then be transaminated back to oxaloacetate by aspartate aminotransferase in the cytosol, using alpha-ketoglutarate as a cofactor. This process also transfers amino groups (glutamate) from the mitochondria to the cytosol.

In the second stage, oxaloacetate is decarboxylated and phosphorylated by phosphoenolpyruvate carboxykinase, an enzyme that requires GTP as a cofactor. The product of this reaction is phosphoenolpyruvate, a three-carbon compound.

The overall reaction for this conversion is:

Pyruvate + ATP + CO2 + H2O -> Phosphoenolpyruvate + ADP + Pi + 2H+

Conversion of fructose 1,6-bisphosphate to fructose-6-phosphate

This reaction is the second step of gluconeogenesis and it occurs in the cytosol. It is catalyzed by fructose 1,6-bisphosphatase, an enzyme that hydrolyzes fructose 1,6-bisphosphate to fructose-6-phosphate and inorganic phosphate. This reaction is irreversible and bypasses the glycolytic enzyme phosphofructokinase-1.

The reaction for this conversion is:

Fructose 1,6-bisphosphate + H2O -> Fructose-6-phosphate + Pi

Conversion of glucose-6-phosphate to glucose

This reaction is the final step of gluconeogenesis and it occurs in the endoplasmic reticulum of liver cells and kidney cells. It is catalyzed by glucose 6-phosphatase, an enzyme that hydrolyzes glucose-6-phosphate to glucose and inorganic phosphate. This reaction is irreversible and bypasses the glycolytic enzyme hexokinase.

The reaction for this conversion is:

Glucose-6-phosphate + H2O -> Glucose + Pi

Glucose can then be transported out of the cell and into the bloodstream by glucose transporters (GLUTs).

These three reactions are essential for gluconeogenesis because they overcome the thermodynamic barriers of reversing glycolysis. They also require energy input from ATP and GTP and reducing power from NADH. The rest of the reactions in gluconeogenesis are simply the reverse of glycolysis and do not require any additional energy or cofactors.

Gluconeogenesis is a vital metabolic pathway that allows the body to maintain a constant level of blood glucose, which is essential for the functioning of the brain, nervous system, and red blood cells. Glucose is the preferred fuel for these tissues and organs, and they cannot use fatty acids or ketone bodies as alternative sources of energy. Therefore, when the dietary intake of carbohydrates is low or the glycogen stores in the liver and muscles are depleted, the body needs to synthesize glucose from non-carbohydrate precursors, such as lactate, glycerol, and certain amino acids. This process is called gluconeogenesis.

Gluconeogenesis occurs mainly in the liver, and to a lesser extent in the kidneys and intestines. The liver is responsible for maintaining the blood glucose level within a narrow range of 70-110 mg/dL. When the blood glucose level falls below this range, the liver increases its gluconeogenic activity to produce more glucose and release it into the bloodstream. This prevents hypoglycemia, which can cause symptoms such as weakness, confusion, seizures, and coma.

Gluconeogenesis also helps to clear the excess lactate that is produced by anaerobic glycolysis in muscles and red blood cells during intense exercise or hypoxia. Lactate is transported to the liver via the Cori cycle, where it is converted back to pyruvate and then to glucose by gluconeogenesis. This recycles the lactate and restores the NAD+ needed for glycolysis.

Another source of gluconeogenic substrates is glycerol, which is released from the breakdown of triglycerides in adipose tissue. Glycerol can be converted to dihydroxyacetone phosphate (DHAP) and then to glyceraldehyde-3-phosphate (G3P) by glycerol kinase and glycerol-3-phosphate dehydrogenase, respectively. These intermediates can then enter the gluconeogenic pathway and be converted to glucose.

Some amino acids can also serve as gluconeogenic precursors, especially alanine, glutamine, and aspartate. These amino acids are derived from the breakdown of proteins in muscles and other tissues. Alanine can be transaminated to pyruvate by alanine aminotransferase, glutamine can be hydrolyzed to glutamate and then deaminated to alpha-ketoglutarate by glutaminase and glutamate dehydrogenase, respectively, and aspartate can be transaminated to oxaloacetate by aspartate aminotransferase. These intermediates can then be converted to phosphoenolpyruvate (PEP) and then to glucose by gluconeogenesis.

In summary, gluconeogenesis is a crucial pathway that ensures a steady supply of glucose for the tissues that depend on it. It also helps to regulate the blood pH by removing excess lactate and to balance the nitrogen metabolism by disposing of excess amino acids. Gluconeogenesis is regulated by hormonal and allosteric factors that coordinate its activity with the energy status and nutritional state of the body.

Deficiency in any of the gluconeogenic enzymes leads to hypoglycemia, which is a condition of low blood glucose levels. Hypoglycemia can cause symptoms such as weakness, confusion, sweating, hunger, and seizures. If left untreated, it can lead to coma and death.

Some of the inherited disorders that affect gluconeogenesis are:

• Pyruvate carboxylase deficiency: This is a rare disorder that impairs the conversion of pyruvate to oxaloacetate. It causes lactic acidosis, developmental delay, seizures, and neurological problems.
• Phosphoenolpyruvate carboxykinase deficiency: This is another rare disorder that affects the conversion of oxaloacetate to phosphoenolpyruvate. It causes hypoglycemia, lactic acidosis, and failure to thrive.
• Fructose-1,6-bisphosphatase deficiency: This is a disorder that prevents the conversion of fructose 1,6-bisphosphate to fructose-6-phosphate. It causes hypoglycemia, lactic acidosis, ketosis, and hepatomegaly (enlarged liver).
• Glucose-6-phosphatase deficiency: This is also known as von Gierke disease or glycogen storage disease type I. It affects the conversion of glucose-6-phosphate to glucose. It causes hypoglycemia, lactic acidosis, hyperuricemia (high uric acid levels), hyperlipidemia (high lipid levels), and hepatomegaly.

These disorders are diagnosed by measuring the enzyme activity in blood cells or liver tissue. Treatment involves dietary management to avoid fasting and provide adequate glucose intake. Some patients may also require supplements of biotin, carnitine, or other cofactors.

Gluconeogenesis is a vital pathway for maintaining blood glucose levels in the body. Any defect in this pathway can have serious consequences for health and survival.

Gluconeogenesis is regulated by hormonal and allosteric factors that control the activity and expression of the key enzymes involved in the pathway. The main hormones that regulate gluconeogenesis are glucagon, insulin, and cortisol.

• Glucagon is secreted by the alpha cells of the pancreas when blood glucose levels are low. Glucagon stimulates gluconeogenesis by activating adenylate cyclase, which increases the level of cyclic AMP (cAMP) in the liver cells. cAMP activates protein kinase A, which phosphorylates and activates fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase, and inhibits pyruvate kinase. Glucagon also induces the transcription of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase genes.
• Insulin is secreted by the beta cells of the pancreas when blood glucose levels are high. Insulin inhibits gluconeogenesis by activating phosphoprotein phosphatase, which dephosphorylates and inactivates fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase, and activates pyruvate kinase. Insulin also represses the transcription of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase genes.
• Cortisol is a glucocorticoid hormone that is secreted by the adrenal cortex in response to stress. Cortisol stimulates gluconeogenesis by inducing the transcription of phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase genes. Cortisol also enhances the availability of substrates for gluconeogenesis by stimulating lipolysis and proteolysis.

In addition to hormonal regulation, gluconeogenesis is also regulated by allosteric factors that modulate the activity of the key enzymes depending on the availability of substrates and energy.

• Pyruvate carboxylase is activated by acetyl-CoA, which is produced from fatty acid oxidation when glucose is scarce.
• Phosphoenolpyruvate carboxykinase is inhibited by ADP and AMP, which indicate low energy status.
• Fructose-1,6-bisphosphatase is inhibited by AMP and fructose 2,6-bisphosphate, which is produced from fructose 6-phosphate by phosphofructokinase 2 (PFK2). PFK2 is activated by insulin and inhibited by glucagon.
• Pyruvate kinase is inhibited by ATP, acetyl-CoA, alanine, and phosphorylation by protein kinase A.

Thus, gluconeogenesis is regulated in a coordinated manner to maintain blood glucose levels within a narrow range and to adapt to the metabolic needs of the body under different physiological conditions.

We are Compiling this Section. Thanks for your understanding.